Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients

Blood Cancer J. 2023 Apr 10;13(1):50. doi: 10.1038/s41408-023-00824-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • Immunity, Cellular
  • Primary Myelofibrosis* / genetics
  • SARS-CoV-2
  • Vaccination